Linagliptin
Back to searchScientific Name: | Linagliptin |
Brand Name: | Glyxambi, Jentadueto, Tradjenta, Trajenta, Trijardy |
Company Owner: | Not Available |
Mechanism Of Action | Linagliptin is a competitive, reversible DPP-4 inhibitor. Inhibition of this enzyme slows the breakdown of GLP-1 and glucose-dependant insulinotropic polypeptide (GIP) |
Description of the Drug: | Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus. |
Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB08882